Source: The Pharma Letter

twoXAR: SK Biopharma and twoXAR collaborate on lung cancer

South Korea CNS medicines specialist SK Biopharmaceuticals and twoXAR, a US artificial intelligence (AI)-driven...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Andrew A. Radin's photo - Co-Founder & CEO of twoXAR

Co-Founder & CEO

Andrew A. Radin

CEO Approval Rating

81/100

Read more